|
Market Closed -
Euronext Paris
01:55:00 22/08/26 am AEST
|
After hours 05:23:31 am | |||
| 0.8500 EUR | +10.39% |
|
0.8540 | +0.47% |
| 17/08 | Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase | MT |
| 16/07 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 449M | - | - | - | - | - |
| 1,109B | |||||
| 644B | - | - | - | ||
| 463B | |||||
| 371B | |||||
| 301B |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
